Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Delivering cost-effective care for COPD in the USA: recent progress and current challenges.

Breunig IM, Shaya FT, Scharf SM.

Expert Rev Pharmacoecon Outcomes Res. 2012 Dec;12(6):725-31. doi: 10.1586/erp.12.69. Review.

PMID:
23252355
2.

Improving the management of chronic obstructive pulmonary disease.

Miller RM, George D, Halbert RJ.

J Healthc Qual. 2005 Mar-Apr;27(2):42-7.

PMID:
16190311
3.

Economic analysis of the Confronting COPD survey: an overview of results.

Wouters EF.

Respir Med. 2003 Mar;97 Suppl C:S3-14.

PMID:
12647938
4.

[Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].

Jahnz-Rózyk K, Targowski T, From S.

Pol Merkur Lekarski. 2009 Mar;26(153):208-14. Polish.

PMID:
19388534
5.

The burden of illness and economic evaluation for COPD.

Ramsey SD, Sullivan SD.

Eur Respir J Suppl. 2003 Jun;41:29s-35s. Review.

6.

Innovations to achieve excellence in COPD diagnosis and treatment in primary care.

Fromer L, Barnes T, Garvey C, Ortiz G, Saver DF, Yawn B.

Postgrad Med. 2010 Sep;122(5):150-64. doi: 10.3810/pgm.2010.09.2212. Review.

PMID:
20861599
8.

The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review.

Toy EL, Gallagher KF, Stanley EL, Swensen AR, Duh MS.

COPD. 2010 Jun;7(3):214-28. doi: 10.3109/15412555.2010.481697. Review.

PMID:
20486821
9.

Telehealthcare management for patients with chronic obstructive pulmonary disease.

Yohannes AM.

Expert Rev Respir Med. 2012 Jun;6(3):239-42. doi: 10.1586/ers.12.28. No abstract available.

PMID:
22788935
10.

[Costs of chronic obstructive pulmonary disease in patients treated in ambulatory care in Poland].

Jahnz-Różyk K, Targowski T, From S, Faluta T, Borowiec L.

Pneumonol Alergol Pol. 2011;79(5):337-42. Polish.

11.

Inappropriate overuse of inhaled corticosteroids for COPD patients: impact on health costs and health status.

de Miguel-Díez J, Carrasco-Garrido P, Rejas-Gutierrez J, Martín-Centeno A, Gobartt-Vázquez E, Hernandez-Barrera V, Gil de MA, Jimenez-Garcia R.

Lung. 2011 Jun;189(3):199-206. doi: 10.1007/s00408-011-9289-0. Epub 2011 Apr 17.

PMID:
21499887
12.

Emergency department management of acute exacerbations of chronic obstructive pulmonary disease in the elderly: the Multicenter Airway Research Collaboration.

Cydulka RK, Rowe BH, Clark S, Emerman CL, Camargo CA Jr; MARC Investigators.

J Am Geriatr Soc. 2003 Jul;51(7):908-16.

PMID:
12834509
13.

The burden of COPD in Italy: results from the Confronting COPD survey.

Dal Negro R, Rossi A, Cerveri I.

Respir Med. 2003 Mar;97 Suppl C:S43-50.

PMID:
12647942
14.

The 2007 GOLD Guidelines: a comprehensive care framework.

Gold PM.

Respir Care. 2009 Aug;54(8):1040-9. Review. Erratum in: Respir Care. 2009 Nov;54(11):1501.

15.

The burden of COPD in the U.S.A.: results from the Confronting COPD survey.

Halpern MT, Stanford RH, Borker R.

Respir Med. 2003 Mar;97 Suppl C:S81-9.

PMID:
12647946
16.

Guidelines for the management of chronic obstructive pulmonary disease.

Buist AS.

Respir Med. 2002 Aug;96 Suppl C:S11-6. Review.

PMID:
12199486
17.

Economic aspects of antimicrobial therapy of acute exacerbations of COPD.

Simoens S, Decramer M, Laekeman G.

Respir Med. 2007 Jan;101(1):15-26. Epub 2006 May 2. Review.

18.

Developing and applying a stochastic dynamic population model for chronic obstructive pulmonary disease.

Hoogendoorn M, Rutten-van Mölken MP, Hoogenveen RT, Al MJ, Feenstra TL.

Value Health. 2011 Dec;14(8):1039-47. doi: 10.1016/j.jval.2011.06.008. Epub 2011 Sep 22.

19.

Cost effectiveness of pharmacological maintenance treatment for chronic obstructive pulmonary disease: a review of the evidence and methodological issues.

Rutten-van Mölken MP, Goossens LM.

Pharmacoeconomics. 2012 Apr;30(4):271-302. doi: 10.2165/11589270-000000000-00000. Review.

PMID:
22409290
20.

Optimizing economic outcomes in the management of COPD.

Dal Negro R.

Int J Chron Obstruct Pulmon Dis. 2008;3(1):1-10. Review.

Supplemental Content

Support Center